How to Help Your Patients Find MetroGel in Stock: A Provider's Guide

MetroGel (metronidazole topical gel) has been a go-to topical rosacea treatment for years. But in 2026, more patients than ever are leaving the pharmacy empty-handed — either because the brand isn't stocked, the 1% strength isn't available, or their insurance won't cover it. As the prescriber, you're in a unique position to reduce these access barriers before the patient ever walks out of your office.

This guide covers practical strategies for helping your patients successfully fill their MetroGel prescriptions — and how to handle situations where that isn't possible.

Understanding Why Patients Struggle to Fill MetroGel

To help your patients effectively, it's worth understanding the specific access barriers at play:

Brand availability: Most pharmacies no longer routinely stock brand-name MetroGel due to generic competition. The brand can retail for $186–$482 for a 60g tube, while generics are available for $22–$78 retail (or less with coupons).

Strength mismatch: The 1% formulation (once-daily) is not carried by all pharmacies. Many stock only the 0.75% twice-daily formulation. If the prescription specifies 1%, the patient may need to visit multiple pharmacies.

Insurance barriers: Brand-name MetroGel is not covered by Medicare Part D. Commercial plans vary — generic is typically Tier 1–2, but a brand-specific prescription may face step-therapy or non-formulary rejection.

Low pharmacy volume: In areas with fewer dermatology prescriptions, smaller chain or independent pharmacies may not reorder metronidazole gel frequently enough, leading to intermittent stock-outs.

Prescribing Strategies That Improve Fill Success Rates

Small adjustments at the point of prescribing can significantly increase the likelihood your patient successfully fills their MetroGel prescription:

1. Write for Generic Metronidazole, Not Brand MetroGel

Unless there is a specific clinical indication for the brand formulation, write your prescription for "metronidazole topical gel" without specifying the brand name, and do not include "Dispense as Written." This allows the pharmacist to fill with whatever generic version is in stock and maximizes the patient's chances of filling same-day.

2. Make the Strength Flexible When Appropriate

If the primary driver for prescribing the 1% strength is once-daily convenience, consider whether you can write the prescription to allow either 0.75% (with twice-daily instructions) or 1% (with once-daily instructions). Adding a note like "may dispense 0.75% with twice-daily dosing" gives the pharmacist flexibility and keeps the therapeutic intent intact.

3. Check Insurance Formulary Before Writing

For Medicare patients in particular, confirm that your intended prescription will be covered. Medicare Part D covers generic metronidazole topical but typically does not cover brand-name MetroGel. Using your EHR's formulary check feature or a tool like Surescripts can flag coverage issues before the patient hits the pharmacy.

4. Direct Patients to medfinder for Pharmacy Locating

For patients in areas where MetroGel availability is inconsistent, recommend medfinder as a resource. Patients enter their medication, strength, and zip code, and medfinder contacts pharmacies near them to find which ones can fill the prescription. Results are texted to the patient. This eliminates the time-consuming process of calling pharmacy after pharmacy and helps identify the right location quickly.

5. Suggest Independent Pharmacies for Special Orders

Independent pharmacies are often more willing to special-order specific formulations that chain pharmacies don't keep in stock. If you have a relationship with a local independent pharmacy, let your staff know they can recommend it to patients struggling to fill MetroGel prescriptions.

When MetroGel Can't Be Found: Clinical Alternatives

If a patient has made a reasonable effort to locate MetroGel and still cannot fill it, the following FDA-approved alternatives are supported by strong clinical evidence:

Azelaic acid 15% gel (Finacea) or 20% cream: Generic available; comparable efficacy to metronidazole; first-choice cost-effective alternative for most patients.

Ivermectin 1% cream (Soolantra): Superior efficacy in head-to-head studies; brand-only; Galderma has a patient access program. Best for patients with moderate-to-severe disease or inadequate response to prior therapy.

Low-dose doxycycline (Oracea 40 mg or generic sub-antimicrobial doxycycline): FDA-approved; appropriate for moderate-to-severe cases; generic doxycycline at 20 mg or 40 mg is inexpensive. Avoid in pregnant patients.

Patient Education Points at the Visit

Before the patient leaves your office, briefly cover:

The difference between brand and generic — they may receive the generic and not realize it's the same medication.

The dosing differences between 0.75% (twice daily) and 1% (once daily) — this prevents confusion if they receive a different strength.

That they should call the office if they can't fill the prescription within a few days, rather than simply abandoning treatment.

Discount tools like GoodRx or SingleCare, which can bring generic metronidazole gel down to $22–$34 for those paying cash.